David Dodds

David Dodds is a seasoned professional with over 35 years of experience in leading interdisciplinary process development groups focused on biocatalysis and organic synthesis. Currently serving as Chief Technology Officer at SynAppBio, Inc. and GALY, David Dodds also holds the position of President at Dodds & Associates LLC, providing advisory services to start-ups in pharma and industrial biotech since 2002. In addition to roles at Rondaxe Pharma and zuChem, David Dodds has served in various capacities at organizations like ASTM International and Lee Enterprises Consulting. Notably, David Dodds has been involved in high-level advisory positions and co-founded Pronghorn Renewables LLC, demonstrating a commitment to innovation in bio-based chemicals and biomanufacturing. Academic credentials include a Ph.D. in Organic Chemistry and post-doctoral research in Molecular Biology, both from prestigious institutions in Canada.